Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 18, 2023

BUY
$315.92 - $397.36 $53,706 - $67,551
170 New
170 $54,000
Q2 2021

Jul 30, 2021

SELL
$372.36 - $412.07 $4,095 - $4,532
-11 Closed
0 $0
Q1 2021

Apr 20, 2021

SELL
$357.26 - $392.57 $25,722 - $28,265
-72 Reduced 86.75%
11 $4,000
Q4 2020

Jan 19, 2021

BUY
$319.05 - $363.32 $20,738 - $23,615
65 Added 361.11%
83 $30,000
Q3 2020

Oct 30, 2020

BUY
$280.08 - $347.78 $2,800 - $3,477
10 Added 125.0%
18 $6,000
Q2 2020

Jul 15, 2020

SELL
$270.93 - $320.3 $375,779 - $444,256
-1,387 Reduced 99.43%
8 $2,000
Q4 2019

Jan 22, 2020

BUY
$281.18 - $322.05 $392,246 - $449,259
1,395 New
1,395 $448,000

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.62B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.